Form 4: GoodRx CFO Karsten Voermann Reports Stock Transactions
SEC Form 4 Filing
Karsten Voermann, CFO of GoodRx Holdings, Inc., reports the disposition of shares to cover tax obligations upon vesting of restricted stock units.
Summary
- On September 8, 2024, Karsten Voermann, the Chief Financial Officer of GoodRx Holdings, Inc., reported transactions involving Class A Common Stock.
- Voermann disposed of 54,064 shares of Class A Common Stock to satisfy tax withholding obligations related to the vesting of restricted stock units.
- Additionally, Voermann disposed of 24,700 shares of Class A Common Stock at a price of $7.71 per share.
- Following these transactions, Voermann directly owns 273,899 shares of Class A Common Stock.
- Voermann also holds 432,512 derivative securities in the form of restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock transactions by a company executive. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a key executive.
Key Dates
| Date | Description |
|---|---|
| December 8, 2022 | Initial vesting date of the restricted stock unit award, with 6.25% of the underlying shares vesting. |
| September 8, 2024 | Date of the reported stock transactions, including the disposition of shares for tax obligations and sale of shares. |
| September 9, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.